92.94
price up icon0.67%   0.62
 
loading
Medtronic Plc stock is traded at $92.94, with a volume of 5.25M. It is up +0.67% in the last 24 hours and up +8.11% over the past month. One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$92.32
Open:
$91.965
24h Volume:
5.25M
Relative Volume:
0.69
Market Cap:
$119.08B
Revenue:
$33.54B
Net Income/Loss:
$4.66B
P/E Ratio:
25.67
EPS:
3.62
Net Cash Flow:
$5.19B
1W Performance:
+3.72%
1M Performance:
+8.11%
6M Performance:
+3.05%
1Y Performance:
+18.46%
1-Day Range:
Value
$91.93
$93.10
1-Week Range:
Value
$89.18
$93.10
52-Week Range:
Value
$78.32
$96.25

Medtronic Plc Stock (MDT) Company Profile

Name
Name
Medtronic Plc
Name
Phone
01135314381700
Name
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Name
Employee
95,000
Name
Twitter
@Medtronic
Name
Next Earnings Date
2025-02-18
Name
Latest SEC Filings
Name
MDT's Discussions on Twitter

Compare MDT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
MDT
Medtronic Plc
92.94 118.29B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
ABT
Abbott Laboratories
126.54 218.59B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.14 157.13B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
403.53 151.59B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
EW
Edwards Lifesciences Corp
80.00 44.46B 5.69B 4.15B 623.10M 6.95

Medtronic Plc Stock (MDT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-30-25 Upgrade Wolfe Research Underperform → Peer Perform
Jun-16-25 Initiated Leerink Partners Outperform
Mar-04-25 Upgrade Citigroup Neutral → Buy
Oct-10-24 Upgrade RBC Capital Mkts Sector Perform → Outperform
Aug-21-24 Reiterated Oppenheimer Perform
Aug-15-24 Upgrade UBS Sell → Neutral
Aug-14-24 Downgrade Stifel Buy → Hold
May-30-24 Initiated Goldman Sell
Jul-19-23 Initiated Robert W. Baird Neutral
Jun-30-23 Initiated CL King Buy
May-30-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-24-23 Upgrade Wells Fargo Equal Weight → Overweight
Mar-29-23 Downgrade UBS Buy → Sell
Jan-09-23 Downgrade RBC Capital Mkts Outperform → Sector Perform
Nov-23-22 Downgrade Citigroup Buy → Neutral
Nov-23-22 Downgrade Oppenheimer Outperform → Perform
Nov-16-22 Downgrade Deutsche Bank Buy → Hold
Oct-18-22 Initiated Barclays Equal Weight
Oct-13-22 Initiated Mizuho Buy
Oct-12-22 Initiated Jefferies Hold
Aug-24-22 Downgrade Raymond James Outperform → Mkt Perform
Jul-06-22 Initiated Wolfe Research Underperform
Jun-01-22 Downgrade Atlantic Equities Overweight → Neutral
May-27-22 Downgrade Needham Buy → Hold
Apr-13-22 Downgrade Truist Buy → Hold
Mar-02-22 Resumed BofA Securities Buy
Jan-10-22 Downgrade BTIG Research Buy → Neutral
Jan-07-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-04-22 Downgrade Piper Sandler Overweight → Neutral
Dec-17-21 Downgrade JP Morgan Overweight → Neutral
Dec-16-21 Downgrade Wells Fargo Overweight → Equal Weight
Dec-10-21 Initiated RBC Capital Mkts Outperform
Jun-10-21 Resumed Cowen Outperform
May-25-21 Initiated Barclays Equal Weight
Apr-15-21 Initiated Atlantic Equities Overweight
Dec-15-20 Upgrade Goldman Sell → Neutral
Dec-15-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-08-20 Upgrade Bernstein Mkt Perform → Outperform
Oct-08-20 Upgrade Stifel Hold → Buy
Sep-11-20 Initiated Wolfe Research Peer Perform
May-14-20 Downgrade DZ Bank Buy → Hold
Mar-30-20 Downgrade Needham Strong Buy → Buy
Mar-25-20 Upgrade DZ Bank Hold → Buy
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Sell
Jan-08-20 Initiated SunTrust Buy
Jan-02-20 Upgrade Guggenheim Neutral → Buy
Jun-05-19 Upgrade Wells Fargo Market Perform → Outperform
Feb-04-19 Reiterated Needham Strong Buy
Jan-03-19 Initiated Deutsche Bank Buy
Jan-02-19 Downgrade Citigroup Buy → Neutral
Dec-19-18 Upgrade JP Morgan Neutral → Overweight
Nov-28-18 Initiated UBS Buy
Oct-16-18 Initiated Barclays Overweight
Aug-27-18 Reiterated Argus Buy
View All

Medtronic Plc Stock (MDT) Latest News

pulisher
05:59 AM

What institutional investors are buying Medtronic plc stockBreakthrough stock performance - jammulinksnews.com

05:59 AM
pulisher
Jul 26, 2025

Medtronic plc (MDT): A Bull Case Theory - MSN

Jul 26, 2025
pulisher
Jul 25, 2025

What analysts say about Medtronic plc stockHigh-yield trading alerts - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Medtronic takes next step to submit bone graft for new FDA indication - MassDevice

Jul 25, 2025
pulisher
Jul 25, 2025

Telemetric Devices Market Set to Witness Significant Growth - openPR.com

Jul 25, 2025
pulisher
Jul 25, 2025

Here's What to Expect From Medtronic's Next Earnings Report - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

U.S. Acute External Ventricular Drain Market Analysis Report 2025-2030 Featuring Medtronic, Integra, LifeSciences, Anuncia Medical, Natus, Fuji Systems, B Braun/Aesculap, Boston Scientific, Abbott - Yahoo Finance

Jul 25, 2025
pulisher
Jul 24, 2025

Medtronic's Fiscal Q1 2026 Earnings Preview: What to ExpectNews and Statistics - IndexBox

Jul 24, 2025
pulisher
Jul 24, 2025

Here's What To Expect From Medtronic's Next Earnings Report - Barchart.com

Jul 24, 2025
pulisher
Jul 23, 2025

Medtronic receives Type 2 label expansion for MiniMed 780G in Europe - MedTech Dive

Jul 23, 2025
pulisher
Jul 23, 2025

Medtronic plc (NYSE:MDT) is largely controlled by institutional shareholders who own 87% of the company - simplywall.st

Jul 23, 2025
pulisher
Jul 23, 2025

Insulin Pumps Market Outlook Report 2025, with Leading Player Profiles for Medtronic, Insulet, Tandem Diabetes Care, and More - Yahoo.co

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Medtronic plc stock priceDynamic profit opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Medtronic plc Stock Analysis and ForecastFree Wealth Planning Blueprint - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Medtronic plc a good long term investmentMarket-crushing profits - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know - Nasdaq

Jul 22, 2025
pulisher
Jul 22, 2025

Medtronic gets EU nod for MiniMed 780G System - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

Medtronic’s (MDT) Role in Medical Devices: A Unique Fit for Halal Portfolios - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

Medtronic (MDT): A Shariah-Compliant Powerhouse in the Evolving Medical Device Sector - AInvest

Jul 22, 2025
pulisher
Jul 21, 2025

Medtronic's Unique Fit for Halal Portfolios: A Surgeon's Sense of Purpose and Accuracy - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Medtronic MiniMed 780G wins CE mark for type 2 diabetes, young children - MassDevice

Jul 21, 2025
pulisher
Jul 21, 2025

Court Nixes Jury Award Over Medtronic's Heart Valve Infringement ClaimMedtronic (NYSE:MDT) - Benzinga

Jul 21, 2025
pulisher
Jul 21, 2025

Medtronic gets EU nod for MiniMed 780G System (MDT:NYSE) - Seeking Alpha

Jul 21, 2025
pulisher
Jul 21, 2025

Medtronic (MDT) Expands MiniMed 780G System Indications with Eur - GuruFocus

Jul 21, 2025
pulisher
Jul 21, 2025

Medtronic expands MiniMed 780G system indications across Europe - Investing.com Australia

Jul 21, 2025
pulisher
Jul 21, 2025

Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes - Medtronic

Jul 21, 2025
pulisher
Jul 20, 2025

10 Magnificent S&P 500 Dividend Stocks Down Over 10% to Buy and Hold Forever - The Motley Fool

Jul 20, 2025
pulisher
Jul 19, 2025

Medtronic wins appeals to avoid $106.5M patent verdict - MSN

Jul 19, 2025
pulisher
Jul 19, 2025

Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict - MassDevice

Jul 19, 2025
pulisher
Jul 18, 2025

Fed. Circ. Frees Medtronic From $125M Patent Judgment - Law360

Jul 18, 2025
pulisher
Jul 18, 2025

Medtronic wins appeal to avoid $106.5M patent verdict (MDT:NYSE) - Seeking Alpha

Jul 18, 2025
pulisher
Jul 18, 2025

Medtronic wins US appeal to overturn $106.5 mln heart-valve patent verdict - Reuters

Jul 18, 2025
pulisher
Jul 18, 2025

Breaking Barriers: Medtronic and Zverev Unite - Il Messaggero

Jul 18, 2025

Medtronic Plc Stock (MDT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices SYK
$403.53
price up icon 1.73%
medical_devices BSX
$106.14
price down icon 0.07%
medical_devices EW
$80.00
price up icon 5.54%
$77.61
price up icon 1.09%
$88.99
price up icon 2.59%
Cap:     |  Volume (24h):